annual accounts payable:
$214.44M+$49.52M(+30.03%)Summary
- As of today (June 22, 2025), SRPT annual accounts payable is $214.44 million, with the most recent change of +$49.52 million (+30.03%) on December 31, 2024.
- During the last 3 years, SRPT annual accounts payable has risen by +$137.70 million (+179.44%).
- SRPT annual accounts payable is now at all-time high.
Performance
SRPT Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$156.10M-$58.34M(-27.20%)Summary
- As of today (June 22, 2025), SRPT quarterly accounts payable is $156.10 million, with the most recent change of -$58.34 million (-27.20%) on March 1, 2025.
- Over the past year, SRPT quarterly accounts payable has increased by +$64.57 million (+70.54%).
- SRPT quarterly accounts payable is now -27.20% below its all-time high of $214.44 million, reached on December 31, 2024.
Performance
SRPT quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SRPT Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.0% | +70.5% |
| 3 y3 years | +179.4% | +189.1% |
| 5 y5 years | +214.9% | +487.0% |
SRPT Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +179.4% | -27.2% | +189.1% |
| 5 y | 5-year | at high | +214.9% | -27.2% | +487.0% |
| alltime | all time | at high | >+9999.0% | -27.2% | >+9999.0% |
SRPT Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $156.10M(-27.2%) |
| Dec 2024 | $214.44M(+30.0%) | $214.44M(+80.5%) |
| Sep 2024 | - | $118.77M(+10.6%) |
| Jun 2024 | - | $107.42M(+17.3%) |
| Mar 2024 | - | $91.54M(-44.5%) |
| Dec 2023 | $164.92M(+72.0%) | $164.92M(+87.5%) |
| Sep 2023 | - | $87.95M(-19.9%) |
| Jun 2023 | - | $109.80M(+2.9%) |
| Mar 2023 | - | $106.71M(+11.3%) |
| Dec 2022 | $95.88M(+24.9%) | $95.88M(-19.1%) |
| Sep 2022 | - | $118.46M(+110.8%) |
| Jun 2022 | - | $56.21M(+4.1%) |
| Mar 2022 | - | $54.01M(-29.6%) |
| Dec 2021 | $76.74M(-30.9%) | $76.74M(+73.8%) |
| Sep 2021 | - | $44.16M(-42.4%) |
| Jun 2021 | - | $76.68M(+0.0%) |
| Mar 2021 | - | $76.65M(-31.0%) |
| Dec 2020 | $111.09M(+63.1%) | $111.09M(+49.1%) |
| Sep 2020 | - | $74.53M(-18.7%) |
| Jun 2020 | - | $91.66M(+244.7%) |
| Mar 2020 | - | $26.59M(-60.9%) |
| Dec 2019 | $68.09M(+101.3%) | $68.09M(-16.9%) |
| Sep 2019 | - | $81.95M(+86.1%) |
| Jun 2019 | - | $44.05M(+66.2%) |
| Mar 2019 | - | $26.50M(-21.7%) |
| Dec 2018 | $33.83M(+299.5%) | $33.83M(+65.8%) |
| Sep 2018 | - | $20.41M(+17.4%) |
| Jun 2018 | - | $17.38M(+0.0%) |
| Mar 2018 | - | $17.38M(+105.3%) |
| Dec 2017 | $8.47M(-71.5%) | $8.47M(+59.2%) |
| Sep 2017 | - | $5.32M(-51.3%) |
| Jun 2017 | - | $10.92M(-60.2%) |
| Mar 2017 | - | $27.45M(-7.6%) |
| Dec 2016 | $29.69M(+46.7%) | $29.69M(+43.5%) |
| Sep 2016 | - | $20.68M(+20.7%) |
| Jun 2016 | - | $17.13M(-8.2%) |
| Mar 2016 | - | $18.67M(-7.7%) |
| Dec 2015 | $20.23M(+63.1%) | $20.23M(+172.3%) |
| Sep 2015 | - | $7.43M(-47.3%) |
| Jun 2015 | - | $14.10M(+51.3%) |
| Mar 2015 | - | $9.32M(-24.9%) |
| Dec 2014 | $12.41M(+53.6%) | $12.41M(+1183.1%) |
| Sep 2014 | - | $967.00K(-26.1%) |
| Jun 2014 | - | $1.31M(-83.0%) |
| Mar 2014 | - | $7.72M(-4.4%) |
| Dec 2013 | $8.08M(+7.3%) | $8.08M(-0.6%) |
| Sep 2013 | - | $8.13M(+20.8%) |
| Jun 2013 | - | $6.73M(-4.9%) |
| Mar 2013 | - | $7.07M(-6.1%) |
| Dec 2012 | $7.53M(-19.8%) | $7.53M(+73.8%) |
| Sep 2012 | - | $4.33M(-50.8%) |
| Jun 2012 | - | $8.81M(+7.5%) |
| Mar 2012 | - | $8.20M(-12.8%) |
| Dec 2011 | $9.40M(+616.7%) | $9.40M(+19.0%) |
| Sep 2011 | - | $7.90M(-28.0%) |
| Jun 2011 | - | $10.97M(+69.3%) |
| Mar 2011 | - | $6.48M(+394.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $1.31M(-5.1%) | $1.31M(-73.5%) |
| Sep 2010 | - | $4.95M(+108.7%) |
| Jun 2010 | - | $2.37M(+34.5%) |
| Mar 2010 | - | $1.76M(+27.5%) |
| Dec 2009 | $1.38M(-31.4%) | $1.38M(-67.9%) |
| Sep 2009 | - | $4.30M(+185.7%) |
| Jun 2009 | - | $1.51M(+17.7%) |
| Mar 2009 | - | $1.28M(-36.5%) |
| Dec 2008 | $2.01M(-33.4%) | $2.01M(-38.2%) |
| Sep 2008 | - | $3.26M(+40.1%) |
| Jun 2008 | - | $2.33M(-31.0%) |
| Mar 2008 | - | $3.37M(+11.3%) |
| Dec 2007 | $3.03M(+115.9%) | $3.03M(-42.6%) |
| Sep 2007 | - | $5.27M(+124.6%) |
| Jun 2007 | - | $2.35M(+24.3%) |
| Mar 2007 | - | $1.89M(+34.8%) |
| Dec 2006 | $1.40M(-24.7%) | $1.40M(+21.2%) |
| Sep 2006 | - | $1.16M(-10.3%) |
| Jun 2006 | - | $1.29M(+3.0%) |
| Mar 2006 | - | $1.25M(-32.8%) |
| Dec 2005 | $1.86M(+27.8%) | $1.86M(+13.4%) |
| Sep 2005 | - | $1.64M(+30.6%) |
| Jun 2005 | - | $1.26M(-20.2%) |
| Mar 2005 | - | $1.57M(+8.1%) |
| Dec 2004 | $1.46M(-52.3%) | $1.46M(+97.6%) |
| Sep 2004 | - | $737.10K(-54.2%) |
| Jun 2004 | - | $1.61M(-9.7%) |
| Mar 2004 | - | $1.78M(-41.6%) |
| Dec 2003 | $3.05M(-32.8%) | $3.05M(+67.9%) |
| Sep 2003 | - | $1.82M(+124.3%) |
| Jun 2003 | - | $810.90K(-28.2%) |
| Mar 2003 | - | $1.13M(-75.1%) |
| Dec 2002 | $4.54M(+63.8%) | $4.54M(+1.6%) |
| Sep 2002 | - | $4.47M(+25.8%) |
| Jun 2002 | - | $3.55M(-16.4%) |
| Mar 2002 | - | $4.25M(+53.2%) |
| Dec 2001 | $2.77M(+114.8%) | $2.77M(+141.1%) |
| Sep 2001 | - | $1.15M(-7.6%) |
| Jun 2001 | - | $1.25M(+2.3%) |
| Mar 2001 | - | $1.22M(-5.7%) |
| Dec 2000 | $1.29M(+84.4%) | $1.29M(+27.3%) |
| Sep 2000 | - | $1.01M(+20.8%) |
| Jun 2000 | - | $839.30K(+64.6%) |
| Mar 2000 | - | $509.90K(-27.2%) |
| Dec 1999 | $700.00K(-22.2%) | $700.00K(+75.0%) |
| Sep 1999 | - | $400.00K(+100.0%) |
| Jun 1999 | - | $200.00K(-60.0%) |
| Mar 1999 | - | $500.00K(-44.4%) |
| Dec 1998 | $900.00K(+350.0%) | $900.00K(0.0%) |
| Sep 1998 | - | $900.00K(+125.0%) |
| Jun 1998 | - | $400.00K(+33.3%) |
| Mar 1998 | - | $300.00K(+50.0%) |
| Dec 1997 | $200.00K(0.0%) | $200.00K(-60.0%) |
| Sep 1997 | - | $500.00K(0.0%) |
| Jun 1997 | - | $500.00K(+150.0%) |
| Mar 1997 | - | $200.00K |
| Dec 1996 | $200.00K | - |
FAQ
- What is Sarepta Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual accounts payable year-on-year change?
- What is Sarepta Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly accounts payable year-on-year change?
What is Sarepta Therapeutics annual accounts payable?
The current annual accounts payable of SRPT is $214.44M
What is the all time high annual accounts payable for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual accounts payable is $214.44M
What is Sarepta Therapeutics annual accounts payable year-on-year change?
Over the past year, SRPT annual accounts payable has changed by +$49.52M (+30.03%)
What is Sarepta Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SRPT is $156.10M
What is the all time high quarterly accounts payable for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly accounts payable is $214.44M
What is Sarepta Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SRPT quarterly accounts payable has changed by +$64.57M (+70.54%)